Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-16

Clinical Trial Update: Pharmacogenetics of Vitamin D Supplementation in Tuberculosis [Phase 3]

View source ↗

Summary

Phase 3 trial assessing pharmacogenetics of vitamin D supplementation in tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: University of Birmingham | Conditions: Tuberculosis | Phase 3 | Status: COMPLETED